DocGo Inc. (DCGO) Operating Margin
- Operating margin · 12 months: Value -62.16%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -62.16% | Operating income / revenue. Period ending 2026-06-30. $-183.19M ÷ $294.72M × 100 ≈ -62.16% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -183.19M USD | Operating Income (Loss) |
| Revenue | 294.72M USD | |
| Cost of products and services | (m) | |
| Research and development | 14.12M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-183.19M | $294.72M | (m) | $14.12M | (m) | -62.16% |
| 2026-03-31 | $-182.75M | $301.71M | (m) | $13.63M | (m) | -60.57% |
| 2025-12-31 | $-178.03M | $322.20M | (m) | $13.56M | (m) | -55.26% |
| 2025-09-30 | $-80.93M | $368.09M | (m) | $13.48M | (m) | -21.99% |
| 2025-06-30 | $-28.81M | $435.97M | (m) | $13.43M | (m) | -6.61% |
| 2025-03-31 | $-1.18M | $520.50M | (m) | $12.84M | (m) | -0.23% |
| 2024-12-31 | $28.69M | $616.56M | (m) | $11.59M | (m) | 4.65% |
| 2024-09-30 | $47.84M | $694.97M | (m) | $11.09M | (m) | 6.88% |
| 2024-06-30 | $46.41M | $742.84M | (m) | $11.18M | (m) | 6.25% |
| 2024-03-31 | $37.83M | $703.37M | (m) | $11.38M | (m) | 5.38% |
| 2023-12-31 | $15.05M | $624.29M | (m) | $10.86M | (m) | 2.41% |
| 2023-09-30 | $3.46M | $533.83M | (m) | $9.39M | (m) | 0.65% |
| 2023-06-30 | $-1.05M | $451.59M | (m) | $7.53M | (m) | -0.23% |
| 2023-03-31 | $4.83M | $435.63M | (m) | $6.11M | (m) | 1.11% |
| 2022-12-31 | $21.83M | $440.52M | (m) | $5.38M | (m) | 4.96% |
| 2022-09-30 | $37.20M | $453.05M | (m) | $5.00M | (m) | 8.21% |
| 2022-06-30 | $34.52M | $434.57M | (m) | $4.48M | (m) | 7.94% |
| 2022-03-31 | $27.33M | $386.92M | (m) | $3.89M | (m) | 7.06% |
| 2021-12-31 | $15.36M | $318.72M | (m) | $3.32M | (m) | 4.82% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |